COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,891 Articles (22,568 medRxiv, 8,323 bioRxiv)

Most recent first Previous |  Page 187: Articles 1861-1870  | Next

Mechanism and spectrum of inhibition of a 4'-cyano modified nucleotide analog against diverse RNA polymerases of prototypic respiratory RNA viruses
Gordon, C. J., Walker, S. M., Tchesnokov, E. P., Kocincova, D., Pitts, J., Siegel, D. S., Perry, J. K., Feng, J. Y., Bilello, J. P., Gotte, M.
10.1101/2024.04.22.590607 — Posted: 2024-04-23
Border quarantine, vaccination and public health measures to mitigate the impact of COVID-19 importations: a modelling study
Lydeamore, M. J., Zachreson, C., Conway, E., Shearer, F. M., Baker, C., Ross, J., Miller, J. C., McCaw, J. M., Geard, N., McVernon, J., Price, D. J.
10.1101/2024.04.22.24305704 — Posted: 2024-04-22
The potential impact of the spreading of highly transmissible Omicron variant XBB.1.5 and JN.1 on the evolution of SARS-CoV-2
Yi, B.
10.1101/2024.04.20.24306131 — Posted: 2024-04-22
The impact of health inequity on regional variation of COVID-19 transmission in England
Rawson, T., Hinsley, W., Sonabend, R., Semenova, E., Cori, A., Ferguson, N. M.
10.1101/2024.04.20.24306121 — Posted: 2024-04-22
Novel Automatic Classification of Human Adult Lung Alveolar Type II Cells Infected with SARS-CoV-2 through Deep Transfer Learning Approach
Turki, T., Al Habib, S., Taguchi, Y.-h.
10.1101/2024.04.22.590420 — Posted: 2024-04-22
Structural basis for the inhibition of coronaviral main proteases by PF-00835231
Zhou, X., Lu, X., Lin, C., Zou, X., Li, W., Zeng, X., Wang, J., Zeng, P., Wang, W., Zhang, J., Jiang, H., Li, J.
10.1101/2024.04.22.590578 — Posted: 2024-04-22
Humoral immunogenicity comparison of XBB and JN.1 in human infections
Jian, F., Yisimayi, A., Song, W., Wang, J., Xu, Y., Chen, X., Yu, Y., Niu, X., Yang, S., Wang, P., Sun, H., Yu, L., Wang, J., Wang, Y., An, R., Wang, W., Xiao, T., Gu, Q., Shao, F., Wang, Y., Shen, Z., Jin, R., Cao, Y.
10.1101/2024.04.19.590276 — Posted: 2024-04-22
Role of Thromboinflammation Interaction in the Serious-Critical COVID-19 Pneumonia: A Single-center Retrospective Study
Li, J., Liu, S.
10.1101/2024.04.19.24306109 — Posted: 2024-04-20
Emergence of SARS-CoV-2 Omicron Variant JN.1 in Tamil Nadu, India Clinical Characteristics and Novel Mutations
Selvavinayagam, S. T., Sankar, S., Yong, Y. K., Murugesan, A., Suvaithenamudhan, S., Hemashree, K., Rajeshkumar, M., Anandhazhvar, K., Pandey, R. P., Shanmugam, S., Arthydevi, P., Kumar, M. S., Gopalan, N., Kannan, M., Cheedarla, N., Tan, H. Y., Zhang, Y., Larsson, M., Balakrishnan, P., Velu, V., Byrareddy, S. N., Esaki Muthu, S., Raju, S.
10.1101/2024.04.16.24305882 — Posted: 2024-04-19
Model-based estimates of age-structured SARS-CoV-2 epidemiology in households
Toth, D. J. A., Sheets, T. R., Beams, A. B., Ahmed, S. M., Seegert, N., Love, J., Keegan, L. T., Samore, M.
10.1101/2024.04.18.24306047 — Posted: 2024-04-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).